Illumina, Inc. announced it will report its second quarter 2026 financial results after market close on July 30, 2026. On the same day, CEO Jacob Thaysen and CFO Ankur Dhingra will host a conference call at 1:30 pm Pacific Time to discuss the results with analysts and investors. The call will be accessible via a live webcast on Illumina's website, with a replay available for 30 days. This event is important for investors to understand Illumina's recent performance and outlook in the genomics and DNA sequencing market.
Illumina dominates the genomics sequencing market with over 90% share, operating in a $30 billion market growing at double-digit rates. The company’s focus on core sequencing, cost control, and capital return after divesting GRAIL is fueling revenue ...
Illumina has named Mike Sullivan as Chief Commercial Officer and Julie Coletti as Chief Legal Officer, bringing extensive experience in life sciences and diagnostics. Sullivan will lead global commercial operations, leveraging over 30 years in health...
